• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

超级肥胖的腹腔镜胃旁路术与腹腔镜十二指肠转位术的随机临床试验。

Randomized clinical trial of laparoscopic gastric bypass versus laparoscopic duodenal switch for superobesity.

机构信息

Departments of Gastrointestinal Surgery, Oslo University Hospital Aker, Oslo, Norway.

出版信息

Br J Surg. 2010 Feb;97(2):160-6. doi: 10.1002/bjs.6802.

DOI:10.1002/bjs.6802
PMID:20035530
Abstract

BACKGROUND

Laparoscopic Roux-en-Y gastric bypass (LRYGB) and laparoscopic biliopancreatic diversion with duodenal switch (LDS) are surgical options for superobesity. A randomized trial was conducted to evaluate perioperative (30-day) safety and 1-year results.

METHODS

Sixty patients with a body mass index (BMI) of 50-60 kg/m(2) were randomized to LRYGB or LDS. BMI, percentage of excess BMI lost, complications and readmissions were compared between groups.

RESULTS

Patient characteristics were similar in the two groups. Mean operating time was 91 min for LRYGB and 206 min for LDS (P < 0.001). One LDS was converted to open surgery. Early complications occurred in four patients undergoing LRYGB and seven having LDS (P = 0.327), with no deaths. Median stay was 2 days after LRYGB and 4 days after LDS (P < 0.001). Four and nine patients respectively had late complications (P = 0.121). Mean BMI at 1 year decreased from 54.8 to 38.5 kg/m(2) after LRYGB and from 55.2 to 32.5 kg/m(2) after LDS; percentage of excess BMI lost was greater after LDS (74.8 versus 54.4 per cent; P < 0.001).

CONCLUSION

LRYGB and LDS can be performed with comparable perioperative safety in superobese patients. LDS provides greater weight loss in the first year.

摘要

背景

腹腔镜 Roux-en-Y 胃旁路术(LRYGB)和腹腔镜胆胰分流加十二指肠转位术(LDS)是治疗超级肥胖的手术选择。一项随机试验评估了围手术期(30 天)安全性和 1 年结果。

方法

将 60 名 BMI 为 50-60kg/m²的患者随机分为 LRYGB 或 LDS 组。比较两组间 BMI、多余体重减轻百分比、并发症和再入院率。

结果

两组患者的特征相似。LRYGB 的平均手术时间为 91 分钟,LDS 为 206 分钟(P<0.001)。1 例 LDS 转为开放手术。LRYGB 术后有 4 例发生早期并发症,LDS 术后有 7 例(P=0.327),无死亡病例。LRYGB 术后中位住院时间为 2 天,LDS 术后为 4 天(P<0.001)。LRYGB 术后分别有 4 例和 LDS 术后有 9 例发生晚期并发症(P=0.121)。LRYGB 术后 1 年 BMI 从 54.8kg/m²降至 38.5kg/m²,LDS 术后从 55.2kg/m²降至 32.5kg/m²;LDS 术后多余体重减轻百分比更大(74.8%比 54.4%;P<0.001)。

结论

LRYGB 和 LDS 可用于超级肥胖患者,围手术期安全性相当。LDS 在术后 1 年内可提供更大的减重效果。

相似文献

1
Randomized clinical trial of laparoscopic gastric bypass versus laparoscopic duodenal switch for superobesity.超级肥胖的腹腔镜胃旁路术与腹腔镜十二指肠转位术的随机临床试验。
Br J Surg. 2010 Feb;97(2):160-6. doi: 10.1002/bjs.6802.
2
Laparoscopic biliopancreatic diversion/duodenal switch or laparoscopic Roux-en-Y gastric bypass for super-obesity-weight loss versus side effects.腹腔镜胆胰分流/十二指肠转位术与腹腔镜 Roux-en-Y 胃旁路术治疗超肥胖症的减重效果与副作用比较。
Surg Obes Relat Dis. 2010 Jul-Aug;6(4):408-14. doi: 10.1016/j.soard.2010.03.293. Epub 2010 Apr 8.
3
Laparoscopic adjustable gastric banding versus Roux-en-Y gastric bypass: 5-year results of a prospective randomized trial.腹腔镜可调节胃束带术与Roux-en-Y胃旁路术:一项前瞻性随机试验的5年结果
Surg Obes Relat Dis. 2007 Mar-Apr;3(2):127-32; discussion 132-3. doi: 10.1016/j.soard.2006.12.005. Epub 2007 Feb 27.
4
Comparison of totally robotic laparoscopic Roux-en-Y gastric bypass and traditional laparoscopic Roux-en-Y gastric bypass.全机器人腹腔镜Roux-en-Y胃旁路术与传统腹腔镜Roux-en-Y胃旁路术的比较
Surg Obes Relat Dis. 2005 Nov-Dec;1(6):549-54. doi: 10.1016/j.soard.2005.08.008.
5
Short-term outcomes for super-super obese (BMI > or =60 kg/m2) patients undergoing weight loss surgery at a high-volume bariatric surgery center: laparoscopic adjustable gastric banding, laparoscopic gastric bypass, and open tubular gastric bypass.在一家大型减肥手术中心接受减肥手术的超级肥胖(BMI≥60 kg/m²)患者的短期结局:腹腔镜可调节胃束带术、腹腔镜胃旁路术和开放式管状胃旁路术。
Surg Obes Relat Dis. 2008 May-Jun;4(3):408-15. doi: 10.1016/j.soard.2007.10.013. Epub 2008 Feb 1.
6
Comparative study between laparoscopic adjustable gastric banding and laparoscopic gastric bypass: single-institution, 5-year experience in bariatric surgery.腹腔镜可调节胃束带术与腹腔镜胃旁路术的比较研究:单机构5年肥胖症手术经验
Surg Obes Relat Dis. 2007 Jan-Feb;3(1):42-50; discussion 50-1. doi: 10.1016/j.soard.2006.11.005.
7
Laparoscopic Roux-en-Y gastric bypass in patients with body mass index >70 kg/m2.腹腔镜 Roux-en-Y 胃旁路手术治疗体重指数>70kg/m2 的患者。
Surg Obes Relat Dis. 2011 Sep-Oct;7(5):587-91. doi: 10.1016/j.soard.2011.02.010. Epub 2011 Mar 12.
8
Is there a benefit to preoperative weight loss in gastric bypass patients? A prospective randomized trial.胃旁路手术患者术前体重减轻有好处吗?一项前瞻性随机试验。
Surg Obes Relat Dis. 2007 Mar-Apr;3(2):141-5; discussion 145-6. doi: 10.1016/j.soard.2006.11.006. Epub 2007 Feb 27.
9
Laparoscopic Roux-en-Y gastric bypass: initial 2-year experience.腹腔镜Roux-en-Y胃旁路术:最初2年的经验
Surg Endosc. 2003 Apr;17(4):603-9. doi: 10.1007/s00464-002-8952-1. Epub 2003 Feb 17.
10
Laparoscopic gastric bypass is superior to adjustable gastric band in super morbidly obese patients: A prospective, comparative analysis.腹腔镜胃旁路手术在超级肥胖患者中优于可调节胃束带术:一项前瞻性比较分析。
Arch Surg. 2006 Jul;141(7):683-9. doi: 10.1001/archsurg.141.7.683.

引用本文的文献

1
Impact of Bariatric Surgery and Endoscopic Therapies on Liver Health in Metabolic Dysfunction-Associated Steatotic Liver Disease: A Review.减重手术和内镜治疗对代谢功能障碍相关脂肪性肝病肝脏健康的影响:综述
J Clin Med. 2025 Jun 6;14(12):4012. doi: 10.3390/jcm14124012.
2
Long-Term Safety and Efficacy Profile of Bariatric Surgery in Patients Classified with ASA IV Status.美国麻醉医师协会(ASA)IV级肥胖症患者接受减肥手术的长期安全性和疗效概况。
Obes Surg. 2025 Mar;35(3):701-714. doi: 10.1007/s11695-025-07753-4. Epub 2025 Feb 19.
3
Challenges in the care and treatment of patients with extreme obesity.
极端肥胖患者的护理和治疗面临的挑战。
Arch Endocrinol Metab. 2024 Jul 18;68:e230335. doi: 10.20945/2359-4292-2023-0335. eCollection 2024.
4
Combined laparoscopic pouch and loop resizing as a revisional procedure for weight regain after primary laparoscopic one-anastomosis gastric bypass.联合腹腔镜下胃囊和肠袢尺寸调整作为初次腹腔镜下单吻合口胃旁路术后体重反弹的修正手术。
J Minim Access Surg. 2023 Jul-Sep;19(3):414-418. doi: 10.4103/jmas.jmas_281_22.
5
First study on the outcomes of biliopancreatic diversion with duodenal switch in Chinese patients with obesity.中国肥胖患者胆胰转流十二指肠转位术结局的首次研究。
Front Surg. 2023 Jan 6;9:934434. doi: 10.3389/fsurg.2022.934434. eCollection 2022.
6
Effect of Obesity and Roux-En-Y Gastric Surgery on Omeprazole Pharmacokinetics.肥胖与 Roux-en-Y 胃旁路手术对奥美拉唑药代动力学的影响。
Obes Facts. 2022;15(2):271-280. doi: 10.1159/000521570. Epub 2022 Jan 3.
7
Role of Gastrointestinal Hormones as a Predictive Factor for Long-Term Diabetes Remission: Randomized Trial Comparing Metabolic Gastric Bypass, Sleeve Gastrectomy, and Greater Curvature Plication.胃肠道激素作为长期糖尿病缓解的预测因素的作用:代谢性胃旁路术、袖状胃切除术和胃大弯折叠术比较的随机试验。
Obes Surg. 2021 Apr;31(4):1733-1744. doi: 10.1007/s11695-020-05192-x. Epub 2021 Jan 5.
8
Clinical practice guidelines of the European Association for Endoscopic Surgery (EAES) on bariatric surgery: update 2020 endorsed by IFSO-EC, EASO and ESPCOP.欧洲内镜外科学会(EAES)关于减重手术的临床实践指南:2020 年更新版,获得国际肥胖与代谢外科学会联合会(IFSO-EC)、欧洲肥胖与代谢外科学会(EASO)和欧洲减重外科学会(ESPCOP)认可。
Surg Endosc. 2020 Jun;34(6):2332-2358. doi: 10.1007/s00464-020-07555-y. Epub 2020 Apr 23.
9
Relationships Between Vitamin D Status and PTH over 5 Years After Roux-en-Y Gastric Bypass: a Longitudinal Cohort Study.Roux-en-Y 胃旁路术后 5 年维生素 D 状态与 PTH 的关系:一项纵向队列研究。
Obes Surg. 2020 Sep;30(9):3426-3434. doi: 10.1007/s11695-020-04582-5.
10
A Multi-institutional Study on the Mid-Term Outcomes of Single Anastomosis Duodeno-Ileal Bypass as a Surgical Revision Option After Sleeve Gastrectomy.一项多机构研究:单吻合口十二指肠空肠旁路术作为袖状胃切除术后手术修正选择的中期结果。
Obes Surg. 2019 Oct;29(10):3165-3173. doi: 10.1007/s11695-019-03917-1.